14931-0 |
Trimipramine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Trimipramine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14931-0 |
|
|
|
|
Both |
|
|
|
0 |
Trimipramine SerPl-sCnc |
|
|
|
Y |
|
Addiction; Cotrimazine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Surmontil; TMP |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14932-8 |
Urate |
PrThr |
Calculus |
Pt |
Ord |
|
|
ACTIVE |
Urate [Presence] in Stone |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14932-8 |
|
|
|
|
Both |
|
|
|
0 |
Urate Stone Ql |
|
|
|
|
|
Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Kidney; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones; UA; Urates; Uric acid |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
14933-6 |
Urate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Urate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14933-6 |
|
|
|
|
Both |
|
|
|
0 |
Urate SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UA; Urates; Uric acid |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14934-4 |
Urate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Urate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14934-4 |
|
|
|
|
Both |
|
|
|
0 |
Urate Ur-sCnc |
|
|
|
Y |
|
Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urates; Uric acid; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14935-1 |
Urate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Urate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
14935-1 |
|
|
|
|
Both |
|
|
|
0 |
Urate 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Kidney; Nephrology; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UR; Urates; Uric acid; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
14936-9 |
Urea nitrogen |
SCnc |
Dial fld prt |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14936-9 |
|
|
|
|
Both |
|
|
|
0 |
Urea nit DiafP-sCnc |
|
|
|
Y |
|
Blood urea nitrogen; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; N; N2; Nit; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UN |
2.7 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
14937-7 |
Urea nitrogen |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14937-7 |
|
|
|
|
Both |
|
|
|
0 |
BUN SerPl-sCnc |
|
|
|
Y |
|
Blood urea nitrogen; BUN; Chemistry; Kidney; Level; N; N2; Nephrology; Nit; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; UN |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
14938-5 |
Urea nitrogen |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Urea nitrogen [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
14938-5 |
|
|
|
|
Both |
|
|
|
0 |
UUN Ur-sCnc |
|
|
|
Y |
|
Blood urea nitrogen; Chemistry; Level; N; N2; Nit; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UN; UR; Urn; UUN |
2.7 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
14939-3 |
Urea nitrogen |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Urea nitrogen [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
14939-3 |
|
|
|
|
Both |
|
|
|
0 |
UUN 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Blood urea nitrogen; Chemistry; Kidney; N; N2; Nephrology; Nit; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UN; UR; Urn; UUN |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
1494-4 |
Glucose^1.5H post 100 g glucose PO |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1494-4 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1.5h p 100 g Glc PO SerPl-mCnc |
|
|
|
Y |
|
1 1/2 hours; 1 1/2 HR; 1.5h p 100 g Glc PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
14940-1 |
Uroporphyrin 1 isomer |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14940-1 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor1 SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Hematology; Heme; i; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Pl; Plasma; Plsm; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Urophorph; Uropor1; Uroporphyrin I |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14941-9 |
Uroporphyrin 1 isomer |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 1 isomer [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14941-9 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor1 Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; i; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration; Urophorph; Uropor1; Uroporphyrin I |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14942-7 |
Uroporphyrin 1 isomer |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 1 isomer [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14942-7 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor1 Ur-sCnc |
|
|
|
Y |
|
Chemistry; Hematology; Heme; i; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Urophorph; Uropor1; Uroporphyrin I |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14943-5 |
Uroporphyrin 3 isomer |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14943-5 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor3 SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Hematology; Heme; III; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Pl; Plasma; Plsm; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Urophorph; Uropor3; Uroporphyrin III |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14944-3 |
Uroporphyrin 3 isomer |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 3 isomer [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14944-3 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor3 Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; III; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration; Urophorph; Uropor3; Uroporphyrin III |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14945-0 |
Uroporphyrin 3 isomer |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Uroporphyrin 3 isomer [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14945-0 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor3 Ur-sCnc |
|
|
|
Y |
|
Chemistry; Hematology; Heme; III; Isom; Level; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Point in time; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Urophorph; Uropor3; Uroporphyrin III |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
14946-8 |
Valproate |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Valproate [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14946-8 |
|
|
|
|
Both |
|
|
|
0 |
Valproate SerPl-sCnc |
|
|
|
Y |
|
Depakene; Divalproex; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VALP; Valproic acid |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
14947-6 |
Vanillylmandelate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Vanillylmandelate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14947-6 |
|
|
|
|
Both |
|
|
|
0 |
VMA 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; 3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
14948-4 |
Vanillylmandelate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Vanillylmandelate/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
14948-4 |
|
|
|
|
Both |
|
|
|
0 |
VMA/Creat Ur-sRto |
|
|
|
Y |
|
3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; CR; Crea; Creat; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; Tumor marker; UA; UCr; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA; VMA & Creat |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
14949-2 |
Vasopressin |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Vasopressin [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
14949-2 |
|
|
|
|
Both |
|
|
|
0 |
Vasopressin Plas-sCnc |
|
|
|
Y |
|
ADH; Adiuretin; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Chemistry; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; VP |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
1495-1 |
Glucose^1.5H post 100 g glucose PO |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1495-1 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 1.5h p 100 g Glc PO Ur-mCnc |
|
|
|
Y |
|
1 1/2 hours; 1 1/2 HR; 1.5h p 100 g Glc PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 100 g Glc PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.34 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
14950-0 |
Viscosity |
Visc |
Synv fld |
Pt |
Ord |
|
|
ACTIVE |
Viscosity of Synovial fluid Qualitative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
14950-0 |
|
|
|
|
Both |
|
|
|
0 |
Visc Snv Ql |
|
|
|
|
|
Joint aspirate; Joint fld; Joint flu; Joint fluid; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SF; SNV; SPEC; Syn; Syn fl; Synov; Synovial fluid; Vicos; Viscos; Viscosity |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14951-8 |
Volatile drugs positive |
Prid |
Ser/Plas |
Pt |
Nom |
Screen |
|
ACTIVE |
Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14951-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
Volatile Drugs Pos SerPl Scn |
|
|
|
|
|
Drug; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Pos; Random; Scn; Scr; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Volatiles |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
14952-6 |
Xylose^1H post 25 g xylose PO |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
14952-6 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 1h p 25 g Xyl PO Bld-sCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p 25 g Xyl PO; 60 min; 60 minutes; 60M; 60min; After; Blood; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 25 g Xyl PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood; Xylose absorption test |
2.4 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
14953-4 |
Xylose^2H post 25 g xylose PO |
SCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L;nmol/L |
|
|
|
|
|
|
CHAL |
|
14953-4 |
|
|
|
|
Observation |
|
|
|
0 |
Xylose 2h p 25 g Xyl PO Bld-sCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 25 g Xyl PO; After; Blood; CHEMISTRY.CHALLENGE TESTING; D-xylose; Level; p 25 g Xyl PO; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood; Xylose absorption test |
2.4 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |